Brief: Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical Co
24/10/2025 02:19
Oct 24 (Reuters) - Tianjin Development Holdings Ltd 0882.HK: 9M NET PROFIT RMB374.3 MILLION FOR TIANJIN LISHENG PHARMACEUTICAL CO 9M TOTAL OPERATING INCOME RMB1.01 BILLION FOR TIANJIN LISHENG PHARMACEUTICAL CO Further company coverage: 0882.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln